February 24, 2022 — Imagine that you are admitted to hospital. A smart scheduling system ensures you have a bed; you sign in with your doctor using facial recognition or a fingerprint scanner; thanks to an efficient digital system, your doctor instantly pulls files with all your medical history; and once a treatment is decided, the prescription is automatically delivered to your bedside—all of this with full transparency, from scheduling to diagnosis, prescription and payment.

February 21, 2022 – The human gut contains trillions of bacteria, collectively called the gut microbiome, which may have positive and negative effects on human health. When in balance they function as an inner chemistry factory producing numerous compounds that promote good health.

February 21, 2022—Nearly 1 percent of all children are born with congenital heart disease—a range of potentially life-threatening problems with the structure and function of their hearts. For most children, the precise causes of these frightening defects are unknown.

February 21, 2022 – A research group the Department of Cardiovascular Medicine, Osaka City University Graduate School of Medicine, has revealed for the first time that the thrombus generated by ulcerated plaque (UP) observed in the femoropopliteal artery (FPA) during angioscopy is the source of embolization of the popliteal artery.

February 21, 2022 – Acute coronary syndromes (such as heart attacks) and strokes are a leading cause of morbidity and mortality in the U.S. and Europe. About 80 percent of those events occur because a build-up of plaque in the arteries—or atherosclerotic plaque (AP)—ruptures.

February 21, 2022 – Nuwellis, Inc. has announced the company will evaluate the clinical outcomes and economic value of its Aquadex therapy in comparison to intravenous diuretics for the treatment of fluid overload in patients with worsening

February 21, 2022 – Researchers at Michigan Medicine have found a novel method of measuring growth in the body’s largest artery that may help clinicians to identify potentially fatal heart conditions earlier.

January 18, 2022 – Evonik Venture Capital has invested in CircumFix Solutions, a Tennessee-based start-up that has developed a new sternal closure device to improve patient recovery after open chest surgery. The patented orthopedic device, made of a high-performance polymer from Evonik, closes and holds the sternum securely together after surgery. 

February 18, 2022 – Daxor Corporation, the global leader in blood volume measurement technology, has announced new data demonstrating the importance and clinical utility of Daxor’s BVA-100 blood test in heart failure (HF) patients published in the

February 18, 2022 – Front Line Medical Technologies, Inc. today announced the expanded availability and distribution of its COBRA-OS (Control of Bleeding, Resuscitation, Arterial Occlusion System), as U.S. and Canadian hospitals continue to implement the life-saving aortic occlusion device during various surgical and emergency cases.

Subscribe Now